The effect of alpha-ipoic acid supplementation along with neuromuscular training in the recovery of multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20190618043934N21
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Relapsing and recovering MS patients with severe disease activity who are treated with rituximab
patients with disability grade 4.5 to 6
Patients who are able to walk without assistance
Patients who can walk at least 100 meters
Age between 20 and 45 years
Exclusion Criteria
Unwillingness of patients to cooperate with the research team
Absence of more than 3 sessions in practice sessions
Not taking alpha lipoic acid medicine regularly
Failure to answer the phone call to continue the treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method